About Hugel
Hugel is a company based in Chuncheon-si (South Korea) founded in 2001 was acquired by CBC Group in May 2022. The company has 609 employees as of December 31, 2024. Hugel has completed 1 acquisition, including JW Cosmetic. Hugel operates in a competitive market with competitors including Revance Therapeutics, Castle Creek Pharma, Dermavant, Sol-Gel Technologies and Bausch Health, among others.
- Headquarter Chuncheon-si, South Korea
- Employees 609 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Hugel, Inc.
-
Annual Revenue
$252.93 M (USD)16.69as on Dec 31, 2024
-
Net Profit
$92.08 M (USD)45.92as on Dec 31, 2024
-
EBITDA
$122.89 M (USD)37.74as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Mubadala
& 4 more
-
Employee Count
609
as on Dec 31, 2024
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Hugel
Hugel is a publicly listed company on the KRX with ticker symbol 145020 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Hugel
Detailed funding history for Hugel
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Hugel
Hugel has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Mubadala, Bain Capital Private Equity and CBC Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private investment firm managing assets and expanding into equity, credit, and real estate services.
|
Locked | Locked | Locked | |
|
Growth stage companies are targeted for private equity investments.
|
Locked | Locked | Locked | |
|
Sovereign wealth fund of United Arab Emirates
|
Locked | Locked | Locked |
Investor details for Hugel
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Hugel
Hugel has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include JW Cosmetic.
Investment portfolio details for Hugel
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Manufacturer of skin care products
|
Locked | Locked | 2015 | Locked |
Complete acquisition details for Hugel
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Hugel
Detailed financials for Hugel
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Hugel Comparisons
Peer comparison for Hugel
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Hugel
Hugel operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Revance Therapeutics, Castle Creek Pharma, Dermavant, Sol-Gel Technologies and Bausch Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Neurotoxin products for aesthetic and therapeutic skin treatments are developed.
|
|
| Locked | Locked | Locked |
Drugs for skin diseases, ENT disorders, and rare diseases such as urea cycle disorders
|
|
| Locked | Locked | Locked |
Small molecule therapeutics for inflammatory skin diseases are developed.
|
|
| Locked | Locked | Locked |
Developing topical drug products for the treatment of rosacea, acne and interdigital tinea pedis.
|
|
| Locked | Locked | Locked |
Therapeutics for multiple diseases including dermatology and neurology are developed.
|
Detailed competitors of Hugel
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Hugel
Complete news archive for Hugel
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hugel
Hugel was founded in 2001.
Hugel is headquartered in Chuncheon-si, South Korea. It is registered at Chuncheon-si, Gangwon-do, South Korea.
As of Dec 31, 2024, the latest employee count at Hugel is 609.
Annual revenue of Hugel is $252.93M as on Dec 31, 2024.
Hugel was founded in 2001 in Chuncheon-si, South Korea, where operations focus on the aesthetics sector. Therapeutics based on botulinum toxin from the Clostridium Botulinum CBFC26 strain are produced for applications such as pediatric cerebral palsy treatment. Biomaterial solutions like Chaeum Premium are also offered for tissue restoration purposes. The companys domain is hugel.co.kr, supporting its work in pharmaceutical development.
Hugel's top competitors include Revance Therapeutics, Dermavant and Bausch Health.
Yes, Hugel is publicly traded on KRX under the ticker symbol 145020.
Hugel has made 1 acquisition, including JW Cosmetic.
Hugel has 5 investors. Key investors include Mubadala, Bain Capital Private Equity, CBC Group, IMM Korea, and GS Holdings.
The ticker symbol of Hugel is 145020 on KRX.